Cryo-Cell International Inc. (OTCMKTS:CCEL) is scheduled to be posting its quarterly earnings results on Monday, October 16th.

Cryo-Cell International (OTCMKTS:CCEL) last posted its quarterly earnings data on Friday, July 7th. The company reported $0.06 earnings per share for the quarter. Cryo-Cell International had a negative return on equity of 21.17% and a negative net margin of 3.59%. The business had revenue of $6.24 million for the quarter.

Cryo-Cell International Inc. (CCEL) opened at 6.766 on Monday. Cryo-Cell International Inc. has a 52-week low of $3.75 and a 52-week high of $7.20. The stock’s market cap is $48.06 million. The firm has a 50-day moving average price of $6.76 and a 200 day moving average price of $6.00.

WARNING: This story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/10/09/cryo-cell-international-inc-ccel-to-release-earnings-on-monday.html.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc is engaged in cellular processing and cryogenic storage. The Company’s segments include cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacture of Prepacyte CB units, the processing technology used to process umbilical cord blood stem cells.

Receive News & Stock Ratings for Cryo-Cell International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International Inc. and related stocks with our FREE daily email newsletter.